Who we are
Claritas is a genetic diagnostic laboratory that has the goal of providing the highest quality testing services for diagnosis of pediatric disorders. Originating as the in-house genetic testing lab at Boston Children’s Hospital, Claritas was launched as a stand-alone entity in February 2013, and in October 2013, Cincinnati Children’s Hospital joined us, beginning the formation of a genomic network of pediatric hospitals. Claritas aims to support institutions as they integrate genomics into the practice of medicine.
May: Chief Commercial Officer, Patrick Terry on reimbursement panel at the Executive War College conference.
April: Claritas launches single gene assays GAA, GBA, GLA, IDUA, SMPD1 for Lysosomal Storage Disorders.
March: Fragile X testing now includes analysis of methylation status on all potentially abnormal samples.
Claritas offers services that support all aspects of the clinical testing experience, from test ordering to providing the most reliable and up-to-date clinical report for each patient. Our tests are derived from the clinical expertise at pediatric hospitals and, if requested, we can connect our clients to subject matter experts for follow-up.
As part of our mission to partner with health care providers to improve patient care, Claritas Genomics is deeply committed to creating resources that further our community’s knowledge about genetics and genomics. Check back often as our content will continue to grow.
Claritas was created to broaden access to the medical genomics expertise in the pediatric community. The company is majority owned and controlled by pediatric hospitals and is connecting the networked hospitals to promote sharing of infrastructure in genetic testing, data for research, expertise and best practices. For more on membership please contact us.